Table: Chugai Pharm -9-MTH group results (IFRS)

Chugai Pharmaceutical

24/10/2018 09:00

Oct 24 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2018        Sep 30, 2017     Dec 31, 2018 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              426.44              387.65                     
                   (+10.0 pct)         (+7.2 pct)                   
  Operating           97.91               76.23                     
                   (+28.4 pct)         (+30.0 pct)                  
  Pretax
  Net                 70.34               57.20                     
                   (+23.0 pct)         (+32.8 pct)                  
  EPS Basic        128.60 yen          104.66 yen                   
  EPS Diluted      128.39 yen          104.51 yen                   
  Ann Div                               62.00 yen        62.00 yen  
  -Q2 Div           31.00 yen           29.00 yen                   
  -Q4 Div                               33.00 yen        31.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T